These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2651185)

  • 1. The course and determinants of insulin action in type 1 (insulin-dependent) diabetes mellitus.
    Nijs HG; Radder JK; Frölich M; Krans HM
    Diabetologia; 1989 Jan; 32(1):20-7. PubMed ID: 2651185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
    Nijs HG; Radder JK; Poorthuis BJ; Krans HM
    Diabetes Res; 1990 Sep; 15(1):15-9. PubMed ID: 2132195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
    Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
    Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose disposal and intermediary metabolism during one year of continuous subcutaneous insulin infusion (CSII).
    Nijs HG; Radder JK; Poorthuis BJ; Krans HM
    Diabetes Res Clin Pract; 1991 Apr; 12(1):1-9. PubMed ID: 1855435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.
    Steen G; Weber RF
    Diabetes Res; 1990 Apr; 13(4):177-82. PubMed ID: 2134209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
    Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
    Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Nielsen S; Schmitz O; Møller N; Pørksen N; Klausen IC; Alberti KG; Mogensen CE
    Diabetologia; 1993 Oct; 36(10):1079-86. PubMed ID: 8243858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.
    Diabet Med; 1994 Jul; 11(6):534-44. PubMed ID: 7955969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients.
    Vukovich TC; Schernthaner G; Knöbi PN; Hay U
    J Clin Endocrinol Metab; 1989 Jul; 69(1):84-9. PubMed ID: 2659619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination and kinetic analysis of non-insulin mediated glucose uptake in type 1 (insulin-dependent) diabetes mellitus.
    Shumak SL; Gulan M; Zinman B; Gottesman IS
    Diabetologia; 1989 Jan; 32(1):28-33. PubMed ID: 2651186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.
    Nielsen S; Schmitz O; Orskov H; Mogensen CE
    Diabetes Care; 1995 Jun; 18(6):834-42. PubMed ID: 7555510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.
    Henriksen JE; Djurhuus MS; Vaag A; Thye-Rønn P; Knudsen D; Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1993 Aug; 36(8):752-8. PubMed ID: 8405743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.
    Vandewalle CL; Decraene T; Schuit FC; De Leeuw IH; Pipeleers DG; Gorus FK
    Diabetologia; 1993 Nov; 36(11):1155-62. PubMed ID: 8270130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
    Fontvieille AM; Rizkalla SW; Penfornis A; Acosta M; Bornet FR; Slama G
    Diabet Med; 1992 Jun; 9(5):444-50. PubMed ID: 1611832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.